Evidence map›Paper›PMID 39724344›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2025

Targeted Activation of Programmed Cell Death Pathways by Optogenetics.

Kateryna Shkarina, Petr Broz

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kateryna ShkarinaInstitute of Innate Immunity, University Hospital Bonn, Bonn, Germany. kateryna.shkarina@uni-bonn.de.
Petr BrozDepartment of Immunobiology, University of Lausanne, Lausanne, Switzerland. petr.broz@unil.ch.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Regulated cell death is an important biological process by which an organism removes unwanted, malignant, or infected cells. Although it has become clear that different forms of regulated cell death exist, it remains difficult to compare their consequences at the cellular and tissue level as they are induced by different stimuli and proceed with different kinetics. Moreover, it was so far difficult to target and induce cell death in selected cells within cell populations or complex tissues without affecting its neighbors. To overcome these obstacles researchers developed novel synthetic biology tools that use chemical or optogenetic approaches to specifically induce PCD in selected cells. Here, we describe a protocol for optogenetic activation of three major types of regulated cell death: apoptosis, necroptosis, and pyroptosis, using light-induced forced oligomerization of their major effector proteins (caspases or kinases).

Indexed as

ApoptosisOptogeneticsAnimalsCaspasesHumansLightNecroptosisPyroptosisSignal TransductionCaspasesApoptosisNecroptosisOptogeneticsPyroptosisRegulated cell death

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.